Evaluating Pharmacogenomic Variants for Cardiology Therapeutics

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

December 3, 2020

Primary Completion Date

July 26, 2023

Study Completion Date

July 27, 2023

Conditions
ThrombosisStent ThrombosisBleedingMyocardial InfarctionIschemic Stroke
Interventions
DIAGNOSTIC_TEST

Cipherome Lighthouse Pilot

Preemptive pharmacogenomic testing

Trial Locations (1)

78539

Doctors Hospital at Renaissance, Edinburg

All Listed Sponsors
collaborator

DHR Health Institute for Research and Development

OTHER

lead

Cipherome, Inc.

INDUSTRY